Hypertension and the heart

Journal of Human Hypertension

Volumn 14, Issue 10-11, 2000, Pages 597-604

  Schmieder, R E ^a   Messerli, F H ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b OCHSNER MEDICAL CENTER   (United States)

Author keywords

Antihypertensive therapy; Left ventricular hypertrophy

Indexed keywords

ALDOSTERONE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; IRBESARTAN; LOSARTAN; METHYLDOPA; VALSARTAN; VASODILATOR AGENT;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; EXERCISE; HEART AFTERLOAD; HEART HEMODYNAMICS; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; LIFESTYLE; META ANALYSIS; POPULATION RESEARCH; PREVALENCE; PROGNOSIS; REMISSION; REVIEW; WEIGHT REDUCTION;

EID: 0033754730     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001044     Document Type: Review

References (92)

1. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study
2. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension
3. Relation of blood pressure and body build to left ventricular mass in normotensive and hypertensive employed adults
4. Increased size of myocardial infarction in dogs with chronic hypertension and left ventricular hypertrophy
5. Acceleration of the wavefront of myocardial necrosis by chronic hypertension and left ventricular hypertrophy in dogs
6. Effects of chronic hypertension and left ventricular hypertrophy on the incidence of sudden cardiac death after coronary artery occlusion in conscious dogs
7. Relations among impaired coronary flow reserve, left ventriculal hypertrophy and thallium perfusion defects in hypertensive patients without obstructive coronary artery disease
8. Hypertension and sudden death: Increased ventricular ectopic activity in left ventricular hypertrophy
9. Echocardiographically determined left ventricular structural and functional correlates of complex or frequent ventricular arrhythmias on one hour ambulatory electrocardiographic monitoring
10. Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS)
11. Echocardiographically detected left ventricular hypertrophy: Prevalence and risk factors. The Framingham Study
12. Prevalence of cardiac structural and functional abnormalities in untreated primary hypertension
13. Dimorphic cardiac adaptation to obesity and arterial hypertension
14. Echocardiographic features of malignant hypertension
15. Echocardiographic left ventricular mass to differentiate chronic hypertension from preeclampsia during pregnancy
16. The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study
17. Does obesity influence early target organ damage in hypertensive patients?
18. Cardiac structure and function in renovascular hypertension produced by unilateral and bilateral renal artery stenosis
19. Differences in left ventricular structural and functional changes between pheochromocytoma and essential hypertension. Role of circulating catecholamines
20. Prevalence of coronary risk factors in elderly blacks and whites
21. Dietary salt intake. A determinant of cardiac involvement in essential hypertension
22. Role of anemia in the pathogenesis of left ventricular hypertrophy in end-stage renal disease
23. Relation of alcohol intake to left ventricular mass: The Framingham Study
24. Sex differences in cardiac adaptation to essential hypertension
25. Correlates of left ventricular mass in a population sample aged 36 to 37 years
26. Left ventricular hypertrophy in patients with hypertension: Importance of blood pressure response to regularly recurring stress
27. Ambulatory blood pressure monitoring and echocardiographic left ventricular wall thickness and mass
28. Early 24-hour blood pressure elevation in normotensive subjects with parental hypertension
29. Relation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension
30. Relation of hemodynamic load to left ventricular hypertrophy and performance in hypertension
31. Central blood volume: A determinant of early cardiac adaptation in arterial hypertension?
32. Parallel cardiac and vascular adaptation in hypertension
33. Whole blood viscosity as a determinant of cardiac hypertrophy in systemic hypertension
34. Gender differences in left ventricular anatomy, blood viscosity and volume regulatory hormones in normal adults
35. Myocardial hypertrophy resulting from low dosage isoproterenol administration in rats
36. Myocardial hypertrophy produced by chronic infusion of subhypertensive dose of norepinephrine in the dog
37. Adrenergic effects on the biology of the adult mammalian cardiocyte
38. Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-β1 expression
39. Converting enzyme inhibitors regressed cardiac hypertrophy and reduced tissue angiotensin II in spontaneously hypertensive rats
40. Does the renin-angiotensin-aldosterone system modify cardiac structure and function in essential hypertension?
41. Angiotensin II related to sodium excretion modulates left ventricular structure in human essential hypertension
42. Inadequate suppression of angiotensin II modulates left ventricular structure in humans
43. Hyper-responsiveness to angiotensin II is related to cardiac structural adaptation in hypertensive subjects
44. ACE inhibitor ramipril is more effective than the β-blocker atenolol in reducing left ventricular mass in hypertension: Results of the RACE (ramipril cardioprotective evaluation) study
45. Angiotensin-converting enzyme inhibitors. Disparities in the mechanism of their antihypertensive effect
46. Remodeling of the rat right and left ventricles in experimental hypertension
47. Reactive and reparative myocardial fibrosis in arterial hypertension in the rat
48. Impact of aldosterone on left ventricular structure and function in normotensive and mildly hypertensive subjects
49. Genetic and environmental influences on echocardiographically determined left ventricular mass in black twins
50. Bivariate genetic analysis of left ventricular mass and weight in pubertal twins (the Medical College of Virginia twin study)
51. Racial differences in cardiac adaptation to essential hypertension determined by echocardiographic indexes
52. Comparison of left ventricular mass and geometry in black and white patients with essential hypertension
53. Impact of left ventricular hypertrophy on survival in end-stage renal disease
54. The clinical course of left ventricular hypertrophy in dialysis patients
55. The prognostic importance of left ventricular geometry in uremic cardiomyopathy
56. The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease
57. Usefulness of echocardiographic left ventricular hypertrophy in predicting new coronary events and atherothrombotic brain infarction in patients over 62 years of age
58. Left ventricular hypertrophy is associated with worse survival independent of ventricular function and number of coronary arteries severely narrowed
59. Congestive heart failure, coronary events, and atherothrombotic brain infarction in elderly blacks and whites with systemic hypertension and with and without echocardiographic and electrocardiographic evidence of left ventricular hypertrophy
60. Reduction of left ventricular mass during treatment of essential hypertension is associated with improved prognosis
61. Management of essential hypertension in patients with different degrees of left ventricular hypertrophy: Multicenter trial
62. Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment
63. Prognostic significance of serial changes in left ventricular mass in essential hypertension
64. Comparison of weight reduction with metoprolol and treatment of hypertension in young overweight patients
65. The effect of weight reduction on left ventricular mass: A randomized controlled trial in young, overweight hypertensive patients
66. Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS)
67. Left ventricular mass reduction during salt depletion in arterial hypertension
68. Treatment of Mild Hypertension Study. Final results
69. Exercise training combined with antihypertensive drug therapy. Effects on lipids, blood pressure, and left ventricular mass
70. Meta-analyses of randomized controlled trials
71. Reversibility of left ventricular hypertrophy by differing types of antihypertensive therapy
72. Reversal of left ventricular hypertrophy in hypertensive patients: A meta-analysis of 109 treatment studies
73. Regression of left ventricular hypertrophy in hypertension: Changing Patterns with successive meta-analyses
74. Reversal of left ventricular hypertrophy in essential hypertension: A meta-analysis of randomized double-blind studies
75. Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996)
76. Reduction of left ventricular mass by short term antihypertensive treatment with isradipine: A double-blind comparison with enalapril
77. Influence of the cardioslective betablockers celiprolol and atenolol on 24-h-blood pressure and left ventricular hypertrophy
78. Different effects of fosinopril and atenolol on wave reflections in hypertensive patients
79. Comparison of nifedipine GITS and hydrochlorothiazide in the management of elderly patients with stage I-III diastolic hypertension
80. Effects of lisinopril vs hydralazine on left ventricular hypertrophy and ambulatory blood pressure monitoring in essential hypertension
81. Antihypertensive treatment with felodipine but not with a diuretic reduces episodes of myocardial ischaemia in elderly patients with hypertension
82. Effects of nitrendipine and captopril on the quality of life in hypertensives with left ventricular hypertrophy
83. Comparative effects of fosinopril and nifedipine on regression of left ventricular hypertrophy in hypertensive patients: A double-blind study
84. Effectiveness of enalapril in combination with low-dose hydrochlorothiazide versus enalapril alone for mild to moderate systemic hypertension in black patients
85. Structural adaptation of the heart in borderline hypertensives in response to blood pressure lowering with captopril
86. The effects of nitrendipine and verapamil on the index of left ventricular mass in elderly hypertensives with left ventricular hypertrophy
87. Effect of verapamil and nitrendipine on left ventricular mass and function (systolic and diastolic) in arterial hypertension
88. Effects of losartan on hypertension and left ventricular mass: A long-term study
89. Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension
90. Rate and extent of left ventricular hypertrophy regression: A comparison of angiotensin II blockade with irbesartan and beta-blockade
91. Increased left-ventricular mass after losartan treatment
92. Long-term effects of losartan on blood pressure and left ventricular structure in essential hypertension